RxDoctor Payments Data

Andrew Frazier, DO

Interventional Pain Medicine · Kansas City, MONPI 1902269566

Payments from drug & device makers

What this record shows

This record is dominated by grants: $26,500 of the $32,040 with a category attached, or 82.7%. 20 manufacturers reported payments, led by Medtronic at 41.0% of the total. Reporting peaked in 2020 at $21,682 and has fallen 99.4% since, to $121 in 2025.

$32,040in general payments, 2019–2025

Across 112 payments — averaging $286.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$13K
  • Abbott$10K
  • Boston Scientific$6K
  • Nevro Corp.$1K
  • Nalu Medical, Inc.$528
  • Painteq LLC$228
  • plus $990 from 14 others

What the payments were for

  • Grants$26,50083%
  • Travel & lodging$1,2684%
  • Food & beverage$4,27313%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,040 in reported general payments places this provider in the 85th percentile of 27 interventional pain medicine providers in Missouri.

See all interventional pain medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$118,876
Medicare patients
374
Services billed
1,289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen62$2,122
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen97$1,708
Gabapentin108$890
Pregabalin29$753
Tizanidine Hcl35$504
Morphine Sulfate ErMorphine Sulfate13$490
Oxycodone Hcl21$481
Tramadol Hcl48$263
Duloxetine Hcl17$219
Baclofen23$179
Methylprednisolone21$121
Cephalexin17$91
Nortriptyline Hcl13$90
Meloxicam38$82
Diazepam21$14

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →